Progress through the cell cycle is determined at discrete points, called check-points, by a family of closely related protein kinases. This family has been christened the 'cyclin-dependent kinases' (CDKs), because they are only activated on binding a member of the cyclin family. In this paper I shall outline the evidence for the involvement of different CDK-cyclin complexes at distinct check-points in the cell cycle.
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cdc2: The first CDK
The concept that the cell cycle is regulated at discrete points was first proposed by Hartwell in his studies on the cell cycle of the budding yeast Sacchuromyces cereviszize [ 13. Hartwell found that defects in certain gene products would cause a cell to stop at particular points in the cell cycle. These genes are called cell-division cycle or cdc genes. The point in the cell cycle at which a cdc mutant is arrested defines the point at which that particular cdc gene product is required. Hartwell proposed that there are a series of check-points in the cell cycle at which the cell will stop and assay intra-and extracellular conditions before going on to the next stage of the cell cycle. Only when conditions are favourable will the cell pass through the checkpoint. For example, a normal cell will not enter mitosis unless its DNA is fully replicated and undamaged. One of the most intriguing cdc genes was isolated by Paul Nurse from the fission yeast Schizosaccharomyces pombe. This gene, cdc2, had the unusual property of causing the cell to stop at either of two discrete points in the cell cycle [2] . cdc2
Mutants would arrest either just before mitosis or at a point called START, which is where a yeast cell committed itself to DNA replication or to mating and sporulation. Nurse isolated and sequenced the cdc2 gene and found that it encoded a 287 amino acid protein with all the hallmarks of a protein kinase. The cdc2 protein kinase has proved to be the paradigm for the CDK family. It is inactive as a monomeric protein and is activated only on binding a cyclin subunit; a START cyclin in GI phase or a mitotic cyclin in GZ phase of the cell cycle.
Abbreviations used: cdc, cell-division cycle; CDK, cyclindependent kinase; K point, restriction point; Rb, retinoblastoma.
Cyclins
The cyclin family of proteins are proteins that undergo a cell-cycle-dependent variation in level, and all bear a significant degree of sequence similarity to one another in -100 amino acid region called the cyclin box (reviewed in [ 3 ] ) . Cyclins were first identified by Tim Hunt in developing sea urchin and clam eggs as proteins that were strongly synthesized during interphase and then very specifically and rapidly destroyed at each mitosis [4] .
Two proteins of apparent M,s 58000 and 62000
were cyclically synthesized and destroyed, and these were named A-and B-type cyclins.
These cyclins are now called 'mitotic cyclins' to distinguish them from the second class of cyclins, START cyclins or CLNs, which reach their peak amount in the GI phase of the cell cycle. These genes were first identified as mutants in budding yeast that affected the size at which the cell divided (reviewed in [5] ). On sequencing, the CLN genes were found to encode proteins that are distantly related to the mitotic cyclins, and the homologous region was called the cyclin box. The mitotic and START cyclins differ in their overall structure.
Mitotic cyclins have approx. 200 amino acids N-terminal to the cyclin box, whereas START cyclins mostly extend C-terminal to the cyclin box and this part of the protein is rich in proline, glutamic acid, serine and threonine arranged as 'PEST' sequences that have been correlated with rapidly turned-over proteins. Putative START cyclins have been isolated recently from human cells. Three classes of human cDNAs were isolated that could substitute for the CLN proteins when introduced into yeast. These have been called C-, D-and E-type cyclins.
Cyclin destruction
The differences in the overall structure of the START and mitotic cyclins relates to differences in their mode of destruction. Mitotic cyclins are stable throughout interphase and are only destroyed in a brief window in mitosis [6] . This property is conferred by the region of the protein that is N-terminal to the cyclin box; when this region is removed, the truncated cyclin cannot be degraded, and this has the effect of blocking a cell in mitosis [7] . The region required for mitotic destruction has been further delineated to a small region around a con-
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any other cdc2-related proteins in multicellular CDK3 in the human cell cycle is unknown.
served arginine residue about 40 amino acids from the N-terminus of the protein [8] . It appears that the destruction of the mitotic cyclins involves the ubiquitin-dependent proteolysis pathway.
The START cyclins lack the N-terminal extension found in the mitotic cyclins, and indeed they differ in being very short-lived proteins that are constantly turned over throughout the cell cycle. Their levels are determined by changes in the rate of transcription of their cognate mRNAs. The C-terminal PEST-rich region appears to be responsible for the rapid turnover of the proteins; without the C-terminus the START cyclins become much more stable proteins. However, unlike their mitotic counterparts, an increase in the amount of CLN protein does not block the cell in the cell cycle, rather it accelerates the progress of the cell through the START checkpoint.
Family of cdc2 homologues in multicellular eukaryotes
Despite their structural differences, in yeast both the mitotic and the START cyclins bind with and activate CDC28 (the cdc2 homologue in budding yeast), but at different stages in the cell cycle [9, 10, 1 11. However, in multicellular organisms it appears that the dual role of cdc2 in the cell cycle, at START and at mitosis, has been split between two gene products. The kinase that is active at mitosis binds with the mitotic B-type cyclin and is still called cdc2, but a second, highly related protein kinase is active at the beginning of DNA replication and is called CDK2 (see [12] for a review). The clearest evidence for the separate roles of cdc2 in mitosis and CDK2 in DNA replication comes from studies on the Xenopus egg cell-free system. Fang and Newport (1991) showed that when a Xenopus egg extract is specifically depleted of cdc2 protein it can still carry out DNA replication, but is unable to enter mitosis [13] . By contrast, when an extract is depleted of CDK2 it can enter mitosis, but can no longer replicate DNA. The high degree of sequence similarity between CDK2 and cdc2 also encouraged researchers to use PCR to search for D-type cyclins: A link between the cell cycle and signal transduction?
However, although the evidence suggests that CDK2 acts at the beginning of S phase in multicellular eukaryotes, this point in the cell cycle comes after the 'restriction' or 'R point' that is thought to approximate to the yeast START point. This is the point in the cell cycle at which the influence of growth factors and cytokines are integrated. There are now good candidates for the cyclin-CDK complexes that are involved in signal transduction from growth factor receptors. These are the D-type cyclins (Dl-3) (reviewed in [15] ) and their associated protein kinases CDK2, CDK5
[ 161 and, primarily, CDK4 [ 171. D-type cyclins can substitute for the yeast START cyclins [18, 191, have been identified as the PRADl [20] and as the bcll [21] proto-oncogenes overexpressed in parathyroid tumours and in lymphomas respectively, and are 'late' genes induced 6-8 h after the stimulation of quiescent macrophages with the colony-stimulating factor-1 growth factor [22] . This corresponds to the R point in these cells. Thus the D-type cyclins are good candidates for activating the CDK required to pass through the R point, and their induction by colony-stimulating factor-1 provides a link between growth factor signal transduction and the cell cycle. In addition, the correlation between abnormal D-type cyclin synthesis and tumorigenesis suggests that perturbations in D-type cyclin synthesis may abrogate the normal proliferation restraints on cells that are thought to act mostly at the R point in cells. This may also involve the retinoblastoma protein (Rb), which is a substrate for the cyclin D-CDK4 complexes in vitro and probably in vivo. Cyclin D2 and cyclin D3 with their associated CDK4 form complexes with Rb [23, 241 , and all three types of cyclin D-CDK4 complexes can overcome the growth inhibitory action of Rb when co-transfected with Rb into SAOS-2 cells [25] . Interestingly, cyclin D is nuclear throughout G, phase, but it disappears from the nucleus once cells enter S phase [26] -whether it is degraded or is translocated to the cytoplasm is as yet unclear. Thus it has been suggested that cyclin Volume 
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Cyclin E is the probable G I 6 cyclin
If it is the D-type cyclins that act at the R point in multicellular organisms, which are the cyclins that are associated with CDK2 at the beginning of DNA replication? The best candidate so far is cyclin E. Cyclin E binds and activates CDK2 [28] , and its synthesis begins late in G, phase, such that it is present in significant amounts at the G, to S phase transition. Once cells enter S phase, cyclin E is rapidly destroyed. Overexpression of cyclin E shortens the length of the G, phase significantly [29] , suggesting that at some point in G, phase the amount of cyclin E normally becomes limiting. The activation of the cyclin E-CDK2 complex also appears to be the point at which transforming growth factor /3 exerts its negative effect on cell proliferation. Transforming growth factor p seems to prevent the activation of the cyclin E-CDK2 complex, although the two proteins can associate [30] . This may be effected by inhibiting the phosphorylation of threonine-160 in CDK2, which is an essential step in the activation of the protein kinase (reviewed in [31] ). Cyclin E, and cyclin A later in S phase, both associate with the Rb-related protein p107 and the transcription factor E2F [32-351, but it is not yet clear what role these complexes play in cell cycle transcription.
Cyclin A is the S and M cyclin; cyclin B is the primary mitotic cyclin A-type cyclins appear to be involved in S phase and in mitosis, whereas the B-types are restricted to mitosis. Cyclin A synthesis begins once cells enter S phase. Like cyclin E, cyclin A is required for DNA replication [36-381, and it is likely that cyclin A phosphorylates the substrates of cyclin E after cyclin E is degraded. However, cyclin A may perform a dual role in the cell cycle; both in DNA replication and in the entry into mitosis. Cyclin A persists until the cell enters metaphase, and exogenously introduced A-type cyclins can induce Xenopus oocytes to enter M phase [39] . In addition, a Drosophila embryo that is deficient in cyclin A will arrest in G, phase [40] .
By contrast R-type cyclins are restricted to mitosis. In association with cdc2 they form the primary mitotic protein kinase (reviewed in [41] ).
Although the R-type cyclins bind with cdc2 in late S phase and in G, phase this complex is prevented from becoming an active kinase through the phosphorylation of the cdc2 subunit. The cdc2 subunit is phosphorylated on the threonine-14 [42] and tyrosine-15 [42, 431 residues that are in the ATP-binding domain. These residues are phosphorylated by the weel [44, 451 and mikl [46] protein kinases. Once the cell is ready to enter mitosis, the weel and mik 1 protein kinase activities are downregulated [47] and the cdc2 subunit associated with cyclin R is dephosphorylated by the cdc25 protein (reviewed in [48] ). cdc25 Is an unusual protein in being both a threonine and a tyrosine phosphatase. cdc25 Also forms part of the feedback pathway between DNA replication and mitosis. Cells will not enter mitosis until their DNA is replicated completely [49] , but this negative inhibition of mitosis by unreplicated DNA requires an active cdc25 protein [50] . The cdc25 protein is activated by phosphorylation at the onset of mitosis, and this phosphorylation is due at least in part to the cyclin B-cdc2 complex. Thus, the activation of cdc25 and cyclin B-cdc2 form a positive feedback loop at the G,/M transition [51, 521.
Lastly, as mentioned above, the mitotic cyclins need to be destroyed for a cell to exit from mitosis, which is the manner in which the cell makes sure that the mitotic kinase is irreversibly inactivated when the cell re-enters interphase. R-type cyclin destruction is strongly correlated with the metaphase-anaphase transition. An indestructible B-type cyclin, in which the N-terminus has been removed or the conserved arginine residue altered, will block a cell in metaphase [7, lo] . Similarly, cells in which the chromosomes are prevented from aligning properly or the spindle is prevented from assembling, will be arrested with a high level of active cyclin €3-cdc2 complex. Only when the chromo-924 somes are correctly aligned on the metaphase plate in readiness to be separated will the B-type cyclins be destroyed, inactivating the mitotic kinase and allowing the cell to enter anaphase.
Conclusion: In multicellular organisms there are separate cyclins and CDKs for different checkpoints in the cell cycle
Our present view of the cell cycle, which is admittedly somewhat speculative and largely based on correlative evidence, is that the different checkpoints in the cell cycle of multicellular eukaryotes are under the control of different cyclin-CDK complexes. Both the constituent cyclins and the CDK subunits can vary in these complexes, and the entire complex may in turn be modulated by phosphorylation. We identify rather tentatively the D-type cyclins with CDK4, and to a lesser extent identify CDK2 and CDK5 with the role of the R point kinase. This roughly corresponds to START in budding yeast, which is known to be controlled by CLN1, -2 and -3 in association with the CDC28 protein kinase. Entry into S phase itself in multicellular organisms seems to be regulated separately by another cyclin-CDK complex, perhaps cyclin E-CDK2 Progress through S phase depends on cyclin A in association with CDK2. At the GL to mitosis transition, cyclin A may also have a role, but the main regulation is through activation of the cyclin R-cdc2 complex by cdc25 as part of a positive feedback loop. Finally, the mitotic state is maintained until the cyclin is degraded at the metaphase-anaphase transition. How the cell senses that conditions are favourable to pass through the check-points, and what are the substrates of the check-point kinases themselves will be the subject of much future study.
